Management of pulmonary hypertension and Down syndrome

International Journal of Clinical Practice

Volumn 65, Issue SUPPL. 174, 2011, Pages 8-13

  King, P ^a   Tulloh, R ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; NITRIC OXIDE; OXYGEN; PROSTACYCLIN; SILDENAFIL;

AMNIOCENTESIS; BLOOD PRESSURE MEASUREMENT; BREATHING EXERCISE; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN SYNDROME; EARLY INTERVENTION; ECHOCARDIOGRAPHY; GASTROESOPHAGEAL REFLUX; HEART CATHETERIZATION; HEART SURGERY; HUMAN; LUNG ARTERY PRESSURE; LUNG DISEASE; LUNG HYPOPLASIA; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; STRUCTURAL LUNG DISEASE; SYMPTOM; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 84055191569     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02823.x     Document Type: Review

References (29)

1. Freeman SB, Taft LF, Dooley KJ, et al., Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80: 213-7. (Pubitemid 28533530)
2. Freeman SB, Bean LH, Allen EG, et al., Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med 2008; 10: 173-80. (Pubitemid 351416813)
3. Geggel RL, O'Brien JE, Feingold M,. Development of valve dysfunction in adolescents and young adults with Down syndrome and no known congenital heart disease. J Pediatr 1993; 122: 821-3. (Pubitemid 23134979)
4. Tulloh RM,. Congenital heart disease in relation to pulmonary hypertension in paediatric practice. Paediatr Respir Rev 2005; 6: 174-80. (Pubitemid 41258647)
5. Greenwood RD, Nadas AS,. The clinical course of cardiac disease in Down's syndrome. Pediatrics 1976; 58: 893-7. (Pubitemid 8000151)
6. Chi TPLKJ,. The pulmonary vascular bed in children with Down syndrome. J Pediatr 1975; 86: 533-8.
7. Wood P,. The eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J 1958; 2: 701-9.
8. Rabinovitch M,. Pathobiology of pulmonary hypertension. Annu Rev Pathol 2007; 2: 369-99. (Pubitemid 46448070)
9. Rabinovitch M, Keane J, Norwood W,. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary haemodynamic findings after repair of congenital heart defects. Circulation 1984; 69: 655-67.
10. Cua CL, Rogers LK, Chicoine LG, et al., Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine. Eur J Pediatr 2011; 170: 859-63.
11. de Miguel-Diez J, Villa-Asensi JR, Alvarez-Sala JL,. Prevalence of sleep-disordered breathing in children with Down syndrome: polygraphic findings in 108 children. Sleep 2003; 26: 1006-9. (Pubitemid 39619762)
12. Martin JE, Howarth KE, Khodaei I, et al., Aryepiglottoplasty for laryngomalacia: the Alder Hey experience. J Laryngol Otol 2005; 119: 958-60. (Pubitemid 41820024)
13. Cooney TP, Thurlbeck WM,. Pulmonary hypoplasia in Down's syndrome. N Engl J Med 1982; 307: 1170-3. (Pubitemid 12037976)
14. Weijerman ME, van Furth AM, van der Mooren MD, et al., Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 2010; 169: 1195-9.
15. Mogra R, Zidere V, Allan LD,. Prenatally detectable congenital heart defects in fetuses with Down syndrome. Ultrasound Obstet Gynecol 2011; 38: 320-4.
16. Galie N, Hoeper MM, Humbert M, et al., Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 2009; 30: 2493-537.
17. Manes A, Campana C,. Pulmonary hypertension: classification and diagnostic algorithm. Ital Heart J 2005; 6: 834-9.
18. Maiya S, Hislop AA, Flynn Y, Haworth SG,. Response to bosentan in children with pulmonary hypertension. Heart 2006; 92: 664-70.
19. Aurora RN, Zak RS, Karippot A, et al., Practice parameters for the respiratory indications for polysomnography in children. Sleep 2011; 34: 379-88.
20. Muthurangu V, Taylor A, Andriantsimiavona R, et al., Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation 2004; 110: 826-34. (Pubitemid 39096011)
21. Muthurangu V, Atkinson D, Sermesant M, et al., Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization. Am J Physiol Heart Circ Physiol 2005; 289: H1301-6. (Pubitemid 41208976)
22. Bowyer JJ, Busst CM, Denison DM, Shinebourne EA,. Effect of long term oxygen treatment at home in children with pulmonary vascular disease. Br Heart J 1986; 55: 385-90. (Pubitemid 16104622)
23. Adriaenssens T, Delcroix M, Van Deyk K, Budts W,. Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome. Eur Heart J 2006; 27: 1472-7. (Pubitemid 43998082)
24. Kermeen FD, Franks C, O'Brien K, et al., Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21. Heart Lung Circ 2010; 19: 595-600.
25. Vis JC, Duffels MG, Mulder P, et al., Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease. Int J Cardiol 2011 Jun 30 (epub ahead of print. PMID 21723630).
26. Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM,. Management of pulmonary hypertension in Down syndrome. Eur J Pediatr 2011; 170: 915-21.
27. Majdalany DS, Burkhart HM, Connolly HM, et al., Adults with Down syndrome: safety and long-term outcome of cardiac operation. Congenit Heart Dis 2010; 5: 38-43.
28. Reller MD, Morris CD,. Is Down syndrome a risk factor for poor outcome after repair of congenital heart defects? J Pediatr 1998; 132: 738-41. (Pubitemid 28194603)
29. Haworth SG,. Pulmonary hypertension in the young. Heart 2002; 88: 658-64. (Pubitemid 35418096)